Business Assets for Sale

Property overview: Location: sector 9, imt bawal, haryana. Strategic proximity: just 200 meters from ICD bawal (inland container depot) Total area: 10,000 sq. Ft. Vastu: north-east facing (highly auspicious) Availability: immediate/ready to move. Shed area: 7,000 sq. Ft. Of well-ventilated, high-clearance industrial space. Heavy-duty flooring: 3,000 sq. Ft features premium epoxy flooring, ideal for dust-free manufacturing, assembly lines, or precision work. Crane provision: pre-built structural provision for overhead crane installation, saving you massive fabrication costs. Power connectivity: dedicated 150 kva ht (high tension) electrical connection already installed for heavy machinery requirements. Premium rcc office block (2,000 sq. Ft. ): Professional frontage: welcoming reception area to host clients and vendors. Meeting facilities: dedicated conference room for team and executive meetings. Guest accommodations: private guest rooms built in, perfect for visiting executives, auditors, or night-shift managers. Utility & storage: ample dedicated storage spaces to keep the shop floor clutter-free. Washrooms: 2 well-maintained washrooms (spanning office and shop floor). Compliance & utilities (zero setup headache): Clearances: all fire, water, and operational nocs/clearances are fully acquired and up to date. Water supply: 24x7 uninterrupted industrial and domestic water supply. Safety: equipped with the necessary fire safety infrastructure.

We are a new type of biotech company dedicated to human cancer gene therapy and have been working on research projects and the development of human gene therapy vectors. - Our company has generated various types of DNA nanoparticles for cancer gene therapy. - Now we have developed new type of RNA nanoparticles called engineered cellular microvesicles (ECM), or RNA microvesicles. - These are purified cytomox/anti-cancer gene products, such as p16, p53, PTEN, CDC6 shRNA, purified ECM-RV/anti-cancer mRNA, such as p16, p53, CDC6 shRNA, GSDME, EZH2 shRNA, Klotho, etc. - The technology includes R&D for the above-mentioned particles and products. - The R&D & the technology are valued at USD 1 million. Additionally, USD 3-4 million will be required to complete the clinical trials, tests, and marketing. - The technology is ready and needs to undergo some tests and clinical trials. - We want to sell the technology and help the buyer to get it patented and market the technology.

We are a new type of biotech company dedicated to human cancer gene therapy and have been working on research projects and the development of human gene therapy vectors. - Our company has generated various types of DNA nanoparticles for cancer gene therapy. - Now we have developed new type of RNA nanoparticles called engineered cellular microvesicles (ECM), or RNA microvesicles. - These are purified cytomox/anti-cancer gene products, such as p16, p53, PTEN, CDC6 shRNA, purified ECM-RV/anti-cancer mRNA, such as p16, p53, CDC6 shRNA, GSDME, EZH2 shRNA, Klotho, etc. - The technology includes R&D for the above-mentioned particles and products. - The R&D & the technology are valued at USD 1 million. Additionally, USD 3-4 million will be required to complete the clinical trials, tests, and marketing. - The technology is ready and needs to undergo some tests and clinical trials. - We want to sell the technology and help the buyer to get it patented and market the technology.

ISO 9001 certified Czech designing and developing company, in cooperation with the Technical University we have developed an attractive small electric vehicle belonging to the L6/L7 category for city transportation. - Vehicles are designed for manufacturing in low CAPEX micro-factories close to consumer markets in order to optimize logistics & increase the efficiency of supply chains. Tools for low cost production have been designed as well. - We are convinced that small electric vehicles are the optimal solution for individual city transport and we bring a chance to participate in this growing market while the sale of vehicles with internal combustion will be reduced. - Our offer to competent and forward-looking entities planning to develop an international business is a license to produce small city electro mobile according to our know-how. - We presume that this project may draw the attention of the investor because it saves money and time rather than starting from zero. - Only the know how is a part of the sale.

The company is selling perpetual usage rights of an AI platform that analyzes microbiome and health data to deliver personalized nutrition and wellness plans. - Partners can deploy and white-label the platform locally, offering premium, data-driven health solutions under their own brand. - The sale includes the proprietary core AI algorithms and source code for the microbiome-based precision diet technology. - Partners receive the right to unlimited API access and the ability to customize and train the AI with local data, ensuring relevance and effectiveness in their market. - The license also grants the right to localized deployment on the partner's local servers for compliance and security, and the autonomy to operate and brand the AI as their own. - The capacity of the AI model is virtually unlimited as it is scalable to the partner's server infrastructure, and its condition is excellent, being actively maintained by us. - The tangible assets required for the operation are minimal and fall primarily under the partner's operational responsibility, reflecting a lean, software-driven business model. - The partner is responsible for managing the inventory of sample collection kits (optional cost of GBP 7.5 per kit), requiring only a small fulfillment/warehouse space for storage and shipping. - We have successfully validated our technology on a global scale, processing over 50,000 microbiome samples across 15+ countries and securing strategic partnerships with major industry players. - Our deep-tech innovation has been recognized with prestigious global awards, including the UK Tech Rocketship Award and victories in the Sanofi and Bayer accelerator programs, establishing us as a trusted leader in the personalized health sector. - The business is driven by a seasoned leadership team, including a serial entrepreneur CEO and a CTO with 15+ years of bioinformatics expertise, ensuring clinical validity and robust architecture. - You can establish a high-margin, end-to-end health service by integrating our software with local Next-Generation Sequencing (NGS) laboratories. - In this model, our partner manages the complete value chain: collecting biological samples, processing them locally, and utilizing our AI to generate premium precision diet and health reports. - These complete diagnostic packages are then sold directly to consumers, medical clinics, and hospitals, allowing the partner to capture the full market value of every test performed. - Alternatively, you can leverage your exclusive regional rights to create a scalable B2B sublicensing ecosystem. - Acting as a master distributor, one can sublicense the software access to other local laboratories, wellness apps, and healthcare networks within the territory. - This allows to generate significant recurring revenue by charging own clients for API access or white-labeled portals, effectively monetizing the technology across the entire region without needing to manage every sample personally. - The company is headquartered in London, while the promoter is currently based in the US and has provided that number for all communications.

Plant used to turn waste material into fuel. - The land is owned by the owner of the business but it is not for sale. - The buyer would get the plant and the assembly line installed in it. - Plant is in excellent working condition and has a processing capacity of 6 tons per day with a total weight of about 25 tons. - It requires 3 men to run the plant. - It has a built-up area of 3,000 sq. ft. - All plastic waste except PVC can be processed.

Automotive body parts manufacturing business selling 2 tilting die-casting machines. - The machines were purchased less than 2 years ago but have only been used for 3 months. - The machine has been manufactured by one of the top brands in India. - Machines can be used in the automotive, hydraulics, and energy industries. - Machines have a platen size (production capacity) of 700*500 mm. - They are in pristine condition and the original bill is available. - The business has GST and incorporation certificates.

An international dry cargo transportation and ship management company. - We provide comprehensive technical and commercial management for dry cargo vessels, including cargo brokerage, sale and purchase, newbuilding consultancy, ship repair consultancy, marine surveys, hull and machinery claims handling, and cargo damage surveys. - Since inception, we have served 39 clients and successfully completed over 80 projects. Currently, we manage three active projects for private investors. - Our objective is to deliver high-quality, reliable, objective, and cost-effective services by aligning business strategies with industry expertise and advanced technology. - The promoter brings more than 20 years of experience in the maritime and shipping industry.